Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2027.

Rhode Island Bill Summary: Insulin Supply Cost Cap

This bill would limit how much people in Rhode Island pay out of pocket for diabetes management supplies. Starting January 1, 2027, insurance plans would be required to cap the cost of a 30-day supply of equipment and supplies used for insulin administration (such as syringes, insulin pens, and needles) and glucose monitoring (such as test strips and continuous glucose monitors) at no more than $25. For equipment designed to last longer than 30 days — like a continuous glucose monitoring device or an insulin pump — insurers would be required to cover it with no deductible, meaning patients wouldn't have to meet a deductible before that coverage kicks in.

This bill would directly affect Rhode Islanders who have diabetes and rely on insulin or need to regularly monitor their blood sugar levels. It would also affect insurance companies, which would be required to restructure their coverage to comply with these new cost limits. The goal is to make essential diabetes supplies more affordable and predictable for patients who need them on an ongoing basis.

The bill has been introduced in the Rhode Island Senate and referred to the Senate Health and Human Services Committee, where it will be reviewed before any further action is taken. It has not yet been passed into law.